NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Pharmaceuticals

19
Companies
with a public disclosure
5
Gave a number
a disclosed NPS
—
Median latest NPS
last 3 years
23
Silent
known companies, nothing published

Lighthouse companies

OPKO Health, Inc.
Pharmaceuticals · opko.com
OPK
92NPS · 2022
Retention 100% · 2022
“Scarlet is now available to more than 150 million homes across the U.S., has a lifetime net promoter score of 92 and a client retention rate of 100%.”
— Oncocyte, management, OPKO Health, Inc. · Earnings call, Q2 2022 · 4 Aug 2022
Latest: Earnings call, Q2 2022
Piramal Pharma Solutions
Pharmaceuticals · piramal.com
55NPS · 2025
“Piramal Pharma Solutions achieved a Net Promoter Score of 55, exceeding industry averages in a third-party assessment by DNV.”
— reported by prnewswire.com · 15 Dec 2025
Latest: prnewswire.com
HanmiGlobal
Pharmaceuticals · hanmiglobal.com
84NPS · 2025
“HanmiGlobal achieved a record Net Promoter Score of 83.5 in H1 2025, the highest since introducing NPS surveys in 2007.”
— reported by biz.chosun.com · 18 Aug 2025
Latest: biz.chosun.com
94NPS · 2025
“A precision medicine company in oncology and rare diseases reported a Patient Satisfaction NPS of 94, far exceeding industry average.”
— reported by ainvest.com · 5 Jul 2025
Latest: ainvest.com
RSSL
Pharmaceuticals
68NPS · 2025
“RSSL achieved an impressive Net Promoter Score of 68, well above industry benchmarks, reflecting its customer service focus.”
— reported by pharmaceuticalmanufacturer.media · 9 Apr 2025
Latest: pharmaceuticalmanufacturer.media

More companies

Number of entries in brackets.

Silent

Companies we know of in pharmaceuticals that have published nothing on NPS or retention.

Fortune 500 #65
Fortune 500 #69
Fortune 500 #142
Fortune 500 #297
Pharmaceutical Company
Pharmaceutical Company
Pharmaceutical Company
Pharmaceutical
Pharmaceuticals
Life Sciences Reagents
Pharmaceutical Developer
Specialty Pharmaceutical
Pharmaceutical & OTC
Pharmaceutical Services
Specialty Pharmaceutical
Pharmaceutical Company
Pharmaceuticals
Pharmaceutical Developer

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.